Wang Lin, Wang Guan-liang, Liu Jia-han, Li Di, Zhu De-zeng, Wu Liang-neng
Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Zhong Xi Yi Jie He Xue Bao. 2012 Jul;10(7):793-9. doi: 10.3736/jcim20120710.
To explore the effects and mechanism of ursolic acid in improving hepatic insulin resistance in KKAy mice with spontaneous type 2 diabetes.
Thirty-five KKAy mice were divided into five groups according to the randomized block design, namely, control, rosiglitazone, fenofibrate, and high- and low-dose ursolic acid groups with seven mice in each group. C57BL/6J mice were used as the normal control group. At the end of the 4th week, free fatty acid (FFA), tumor necrosis factor-α (TNF-α) and adiponectin contents in serum were detected by enzyme-linked immunosorbent assay; the protein expressions of phosphoenolpyruvate carboxykinase (PEPCK), insulin receptor substrate-2 (IRS-2) and glucose transport factor-2 (GLUT-2) were detected by Western blot method; the mRNA expressions of PEPCK, IRS-2 and GLUT-2 were detected by real-time polymerase chain reaction; the expressions of peroxisome proliferator-activated receptor α (PPARα) and peroxisome proliferator-activated receptor γ (PPARγ) in liver tissue were detected by immunohistochemical method.
After four weeks of intervention, the contents of FFA, TNF-α and adiponectin in serum of the high-dose ursolic acid group had changed, showing statistically significant difference compared to those of the control group (P<0.01); high dose of ursolic acid had depressant effect on the expressions of PEPCK protein and PEPCK mRNA (P<0.01); low dose of ursolic acid depressed the expression of PEPCK mRNA and induced phosphorylation of IRS-2 in the liver (P<0.05); both high and low dose of ursolic acid improved the expression of PPARα in the liver (P<0.01).
The effects of ursolic acid in improving hepatic insulin resistance in KKAy mice with spontaneous type 2 diabetes may be closely related to affecting the contents of FFA, TNF-α and adiponectin, improving the expression of PPARα protein, regulating transcription of PEPCK protein and inducing phosphorylation of IRS-2.
探讨熊果酸改善自发性2型糖尿病KKAy小鼠肝脏胰岛素抵抗的作用及机制。
将35只KKAy小鼠按随机区组设计分为5组,即对照组、罗格列酮组、非诺贝特组、高剂量熊果酸组和低剂量熊果酸组,每组7只。以C57BL/6J小鼠作为正常对照组。第4周结束时,采用酶联免疫吸附测定法检测血清中游离脂肪酸(FFA)、肿瘤坏死因子-α(TNF-α)和脂联素含量;采用蛋白质印迹法检测磷酸烯醇式丙酮酸羧激酶(PEPCK)、胰岛素受体底物-2(IRS-2)和葡萄糖转运因子-2(GLUT-2)的蛋白表达;采用实时聚合酶链反应检测PEPCK、IRS-2和GLUT-2的mRNA表达;采用免疫组织化学法检测肝脏组织中过氧化物酶体增殖物激活受体α(PPARα)和过氧化物酶体增殖物激活受体γ(PPARγ)的表达。
干预4周后,高剂量熊果酸组血清中FFA、TNF-α和脂联素含量发生变化,与对照组相比差异有统计学意义(P<0.01);高剂量熊果酸对PEPCK蛋白和PEPCK mRNA表达有抑制作用(P<0.01);低剂量熊果酸抑制肝脏中PEPCK mRNA表达并诱导IRS-2磷酸化(P<0.05);高剂量和低剂量熊果酸均能改善肝脏中PPARα的表达(P<0.01)。
熊果酸改善自发性2型糖尿病KKAy小鼠肝脏胰岛素抵抗的作用可能与影响FFA、TNF-α和脂联素含量、改善PPARα蛋白表达、调节PEPCK蛋白转录及诱导IRS-2磷酸化密切相关。